SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s disease
Abstract Background Human tauopathies including Alzheimer’s disease (AD) are characterized by alterations in the post-translational modification (PTM) pattern of Tau, which parallel the formation of insoluble Tau aggregates, neuronal dysfunction and degeneration. While PTMs on aggregated Tau have be...
Main Authors: | Maria Bichmann, Nuria Prat Oriol, Ebru Ercan-Herbst, David C. Schöndorf, Borja Gomez Ramos, Vera Schwärzler, Marie Neu, Annabelle Schlüter, Xue Wang, Liang Jin, Chenqi Hu, Yu Tian, Janina S. Ried, Per Haberkant, Laura Gasparini, Dagmar E. Ehrnhoefer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-021-00468-x |
Similar Items
-
Structure, activity and function of the lysine methyltransferase SETD5
by: Mingyang Li, et al.
Published: (2023-02-01) -
The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase
by: Apolonia Witecka, et al.
Published: (2021-10-01) -
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
by: Olivier Binda
Published: (2020-02-01) -
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain
by: Ebru Ercan-Herbst, et al.
Published: (2019-12-01) -
Identification of protein lysine methylation readers with a yeast three-hybrid approach
by: Agnieszka Anna Rawłuszko-Wieczorek, et al.
Published: (2018-01-01)